Veterinary Medicines

Trilotab 120 mg chewable tablets for

Authorised
  • Trilostane
Download as PDF

Product identification

Medicine name:
Trilotab 120 mg chewable tablets for
Trilotab 120 mg kauwtabletten voor honden
Active substance:
  • Trilostane
Target species:
  • Dog
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Trilostane
    120.00
    milligram(s)
    /
    1.00
    Tablet
Pharmaceutical form:
  • Chewable tablet
Withdrawal period by route of administration:
  • Oral use
    • Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QH02CA01
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Netherlands
Package description:
  • Aluminium-PVC/Aluminium/oPA blisters, containing 10 tablets. Cardboard box of 10 blisters of 10 tablets
  • Aluminium-PVC/Aluminium/oPA blisters, containing 10 tablets. Cardboard box of 3 blister of 10 tablets

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Hybrid application – change in strength (Article 19(1)(a) of Regulation (EU) 2019/6)
Marketing authorisation holder:
  • CP-Pharma Handelsgesellschaft mbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • CP-Pharma Handelsgesellschaft mbH
Responsible authority:
  • Medicines Evaluation Board
Authorisation number:
  • REG NL 129613
Date of authorisation status change:
Reference member state:
  • Netherlands
Procedure number:
  • NL/V/0373/004
Concerned member states:
  • Austria
  • Belgium
  • Czechia
  • Denmark
  • Estonia
  • Finland
  • France
  • Germany
  • Hungary
  • Ireland
  • Italy
  • Latvia
  • Lithuania
  • Poland
  • Portugal
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom (Northern Ireland)

Documents

Combined File of all Documents

English (PDF)
Published on: 22/08/2023
Updated on: 23/08/2023
Download
Dutch (PDF)
Published on: 6/03/2024
Download

PuAR Trilotab NL_V_0373_001-005_DC 2023-08.pdf

English (PDF)
Published on: 25/08/2023
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."